Indibulin
N/A
Report date: 2022/11/25 18:10:18
NME
Base Information
Drug NameIndibulin
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZiopharm Oncology Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAlaunos Therapeutics Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksKEGG